Rwanda | UK | ||
---|---|---|---|
Patients | n = 4 | n = 5 | – |
Male (%) | 2 (50%) | 4 (80%) | – |
Age at diagnosisa (months) | 57 (6–73) | 13 (2–40) | p = 0.09** |
Weight in kg a | 14 (8–21) | 9.8 (5–14) | |
Z score | − 1.57 (− 3.86–0.85) | − 0.7 (1.2 to − 0.91) | p = 0.28** |
Height in cma | 93.75 (59–117) | 86.65 (73.3–100) | |
Z score | − 2.2 (− 2.4–0.72) | 1.45 (1.4–1.5) | p = 0.057** |
Stage | |||
I–II | 1 | 3 | – |
III–IV | 3 | 2 | – |
Pre-operative chemotherapy | 2 | 3 | – |
Surgery | 1 | 3 | – |
Post-operative morbidity (Clavien-Dindo) | |||
I–II | 1 | 2 | – |
III–IV | 0 | 1 | – |
Mortality (%) | 1 (25%) | 0 | – |